Ramsay A - Search Results

1

Remission after radiotherapy for a patient with chemotherapy-refractory HIV-associated primary effusion lymphoma.

Cassoni A, Ali U, Cave J, Edwards SG, Ramsay A, Miller RF, Lee SM. Cassoni A, et al. Among authors: ramsay a. J Clin Oncol. 2008 Nov 10;26(32):5297-9. doi: 10.1200/JCO.2008.18.3350. Epub 2008 Oct 14. J Clin Oncol. 2008. PMID: 18854561 Free article. No abstract available.

2

The response of HIV-associated lymphadenopathic Kaposi sarcoma to highly active antiretroviral therapy evaluated by 18F-FDG PET/CT.

Mankia SK, Miller RF, Edwards SG, Ramsay A, Lee SM. Mankia SK, et al. Among authors: ramsay a. Clin Nucl Med. 2012 Jul;37(7):692-3. doi: 10.1097/RLU.0b013e3182485261. Clin Nucl Med. 2012. PMID: 22691516

3

A declining CD4 count and diagnosis of HIV-associated Hodgkin lymphoma: do prior clinical symptoms and laboratory abnormalities aid diagnosis?

Gupta RK, Marks M, Edwards SG, Smith K, Fletcher K, Lee SM, Ramsay A, Copas AJ, Miller RF. Gupta RK, et al. Among authors: ramsay a. PLoS One. 2014 Feb 4;9(2):e87442. doi: 10.1371/journal.pone.0087442. eCollection 2014. PLoS One. 2014. PMID: 24504076 Free PMC article.

4

Highly active antiretroviral therapy alone is an effective treatment for lymphadenopathic kaposi sarcoma demonstrated by a clinical and F-18 FDG positron emission tomography/computed tomography response.

Mankia SK, Miller RF, Edwards SG, Ramsay A, Lee SM. Mankia SK, et al. Among authors: ramsay a. Clin Oncol (R Coll Radiol). 2012 May;24(4):309-11. doi: 10.1016/j.clon.2012.01.006. Clin Oncol (R Coll Radiol). 2012. PMID: 22449790 No abstract available.

5

Thymic 18F-fluorodeoxyglucose uptake on positron emission tomography scanning after doxorubicin, bleomycin, vincristin and dacarbazine chemotherapy and highly-active antiretroviral therapy in HIV-associated Hodgkin's disease in an adult.

Lee SM, Buchler T, Bomanji J, Ramsay A, Edwards SG. Lee SM, et al. Among authors: ramsay a. AIDS. 2008 Jan 2;22(1):159-60. doi: 10.1097/QAD.0b013e3282f178ef. AIDS. 2008. PMID: 18090408 No abstract available.

6

Highly active antiretroviral therapy alone may be an effective treatment for HIV-associated multi-centric Castleman's disease.

Lee SM, Edwards SG, Chilton DN, Ramsay A, Miller RF. Lee SM, et al. Among authors: ramsay a. Haematologica. 2010 Nov;95(11):1979-81. doi: 10.3324/haematol.2010.027441. Epub 2010 Aug 26. Haematologica. 2010. PMID: 20801900 Free PMC article. No abstract available.

7

In Vivo Molecular Dissection of the Effects of HIV-1 in Active Tuberculosis.

Bell LC, Pollara G, Pascoe M, Tomlinson GS, Lehloenya RJ, Roe J, Meldau R, Miller RF, Ramsay A, Chain BM, Dheda K, Noursadeghi M. Bell LC, et al. Among authors: ramsay a. PLoS Pathog. 2016 Mar 17;12(3):e1005469. doi: 10.1371/journal.ppat.1005469. eCollection 2016 Mar. PLoS Pathog. 2016. PMID: 26986567 Free PMC article.

8

Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial.

Mauz-Körholz C, Landman-Parker J, Balwierz W, Ammann RA, Anderson RA, Attarbaschi A, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Claviez A, Daw S, Dieckmann K, Fernández-Teijeiro A, Fosså A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kluge R, Kurch L, Leblanc T, Mann G, Montravers F, Pears J, Pelz T, Rajić V, Ramsay AD, Stoevesandt D, Uyttebroeck A, Vordermark D, Körholz D, Hasenclever D, Wallace WH. Mauz-Körholz C, et al. Among authors: ramsay ad. Lancet Oncol. 2022 Jan;23(1):125-137. doi: 10.1016/S1470-2045(21)00470-8. Epub 2021 Dec 9. Lancet Oncol. 2022. PMID: 34895479 Free PMC article. Clinical Trial.

9

Importance of expert central review in the diagnosis of lymphoid malignancies in a regional cancer network.

Proctor IE, McNamara C, Rodriguez-Justo M, Isaacson PG, Ramsay A. Proctor IE, et al. Among authors: ramsay a. J Clin Oncol. 2011 Apr 10;29(11):1431-5. doi: 10.1200/JCO.2010.31.2223. Epub 2011 Feb 22. J Clin Oncol. 2011. PMID: 21343555

10

A Phase I Clinical Trial of CHT-25 a 131I-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma.

Dancey G, Violet J, Malaroda A, Green AJ, Sharma SK, Francis R, Othman S, Parker S, Buscombe J, Griffin N, Chan PS, Malhotra A, Woodward N, Ramsay A, Ross P, Lister TA, Amlot P, Begent R, McNamara C. Dancey G, et al. Among authors: ramsay a. Clin Cancer Res. 2009 Dec 15;15(24):7701-7710. doi: 10.1158/1078-0432.CCR-09-1421. Clin Cancer Res. 2009. PMID: 20008855

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

802 results

Search Page

Filters